Found: 160
Select item for more details and to access through your institution.
A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. e1012, doi. 10.1093/oncolo/oyae073
- By:
- Publication type:
- Article
IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
- Published in:
- Oncology Research, 2024, v. 32, n. 4, p. 625, doi. 10.32604/or.2023.031053
- By:
- Publication type:
- Article
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00627-5
- By:
- Publication type:
- Article
Hypoxia within tumor microenvironment characterizes distinct genomic patterns and aids molecular subtyping for guiding individualized immunotherapy.
- Published in:
- Journal of Big Data, 2024, v. 11, p. 1, doi. 10.1186/s40537-024-00945-2
- By:
- Publication type:
- Article
METTL14 regulates CD8<sup>+</sup>T-cell activation and immune responses to anti‐PD‐1 therapy in lung cancer.
- Published in:
- World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03402-9
- By:
- Publication type:
- Article
Association of a decreased platelet count with poor survival in patients with adult secondary hemophagocytic lymphohistiocytosis.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 4, p. 1159, doi. 10.1007/s00277-024-05663-6
- By:
- Publication type:
- Article
Fat mass and obesity-associated protein (FTO) mediated m<sup>6</sup>A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay.
- Published in:
- Molecular Biomedicine, 2024, v. 5, n. 1, p. 1, doi. 10.1186/s43556-024-00172-4
- By:
- Publication type:
- Article
Cancer‐derived non‐coding RNAs endow tumor microenvironment with immunosuppressive properties.
- Published in:
- Wiley Interdisciplinary Reviews: RNA, 2024, v. 15, n. 1, p. 1, doi. 10.1002/wrna.1822
- By:
- Publication type:
- Article
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 21, p. 2064, doi. 10.1001/jama.2023.19918
- By:
- Publication type:
- Article
Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNApositive gastric and gastroesophageal junction adenocarcinoma: a protocol for a randomized, controlled, multicenter phase II clinical trial (EXPLORING study).
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1232858
- By:
- Publication type:
- Article
IL‐17 induces non‐small cell lung cancer metastasis via GCN5‐dependent SOX4 acetylation enhancing MMP9 gene transcription and expression.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 9, p. 1399, doi. 10.1002/mc.23585
- By:
- Publication type:
- Article
The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00420-3
- By:
- Publication type:
- Article
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01454-z
- By:
- Publication type:
- Article
Prognostic value of the albuminbilirubin score in patients with non-Hodgkin lymphomaassociated hemophagocytic lymphohistiocytosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1162320
- By:
- Publication type:
- Article
Safety, efficacy, and pharmacokinetics of SH‐1028 in EGFR T790M‐positive advanced non–small cell lung cancer patients: A dose‐escalation phase 1 study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 10, p. 1513, doi. 10.1002/cncr.34697
- By:
- Publication type:
- Article
LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m<sup>6</sup>A‐YTHDF2‐dependent manner.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 3, p. 1, doi. 10.1002/ctm2.1205
- By:
- Publication type:
- Article
Aspirin increases the efficacy of gemcitabine in pancreatic cancer by modulating the PI3K/AKT/mTOR signaling pathway and reversing epithelial‑mesenchymal transition.
- Published in:
- Oncology Letters, 2023, v. 25, n. 3, p. N.PAG, doi. 10.3892/ol.2023.13687
- By:
- Publication type:
- Article
Prognostic value of lipid profile in adult hemophagocytic lymphohistiocytosis.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1083088
- By:
- Publication type:
- Article
Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B/CDK8-STAT3 feedback loop.
- Published in:
- Journal of Translational Medicine, 2023, p. 1, doi. 10.1186/s12967-023-03933-x
- By:
- Publication type:
- Article
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy.
- Published in:
- Cancer Communications, 2022, v. 42, n. 12, p. 1331, doi. 10.1002/cac2.12383
- By:
- Publication type:
- Article
Dissecting the Immunological Profiles in NSD3 -Amplified LUSC through Integrative Multi-Scale Analyses.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 4997, doi. 10.3390/cancers14204997
- By:
- Publication type:
- Article
Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.882471
- By:
- Publication type:
- Article
Correlation Analysis of Serum Pepsinogen, Interleukin, and TNF-α with Hp Infection in Patients with Gastric Cancer: A Randomized Parallel Controlled Clinical Study.
- Published in:
- Computational & Mathematical Methods in Medicine, 2022, p. 1, doi. 10.1155/2022/9277847
- By:
- Publication type:
- Article
Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.997842
- By:
- Publication type:
- Article
A nomogram to predict survival probability of gastric cancer patients undergoing radical surgery and adjuvant chemotherapy.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.893998
- By:
- Publication type:
- Article
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
- Published in:
- Theranostics, 2022, v. 12, n. 9, p. 4181, doi. 10.7150/thno.73235
- By:
- Publication type:
- Article
Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.909035
- By:
- Publication type:
- Article
Exosome‐transmitted miR‐769‐5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.780
- By:
- Publication type:
- Article
Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-01033-1
- By:
- Publication type:
- Article
Hsa_circ_0007967 promotes gastric cancer proliferation through the miR-411-5p/MAML3 axis.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-00954-1
- By:
- Publication type:
- Article
Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.799988
- By:
- Publication type:
- Article
Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2).
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28408-3
- By:
- Publication type:
- Article
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00751-9
- By:
- Publication type:
- Article
A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.796647
- By:
- Publication type:
- Article
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00751-9
- By:
- Publication type:
- Article
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00751-9
- By:
- Publication type:
- Article
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703).
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1693, doi. 10.1002/onco.13857
- By:
- Publication type:
- Article
Genomic Profiling Reveals the Molecular Landscape of Gastrointestinal Tract Cancers in Chinese Patients.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.608742
- By:
- Publication type:
- Article
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial
- Published in:
- Cancer Communications, 2021, v. 41, n. 9, p. 889, doi. 10.1002/cac2.12179
- By:
- Publication type:
- Article
Crosstalk between Environmental Inflammatory Stimuli and Non-Coding RNA in Cancer Occurrence and Development.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4436, doi. 10.3390/cancers13174436
- By:
- Publication type:
- Article
Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 4439, doi. 10.2147/OTT.S307273
- By:
- Publication type:
- Article
The Synergistic Effects of Celastrol in combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study.
- Published in:
- BioDrugs, 2021, v. 35, n. 4, p. 445, doi. 10.1007/s40259-021-00484-9
- By:
- Publication type:
- Article
Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 823, doi. 10.1007/s10120-021-01175-8
- By:
- Publication type:
- Article
The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 2, p. 562, doi. 10.20892/j.issn.2095-3941.2020.0187
- By:
- Publication type:
- Article
Metabolic disposition of [<sup>14</sup>C]‐abivertinib, an epidermal growth factor receptor tyrosine kinase inhibitor: Role of glutathione conjugation.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1475, doi. 10.1111/bcp.14555
- By:
- Publication type:
- Article
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1681, doi. 10.1002/cam4.3771
- By:
- Publication type:
- Article
Functional genetic variant of HSD17B12 in the fatty acid biosynthesis pathway predicts the outcome of colorectal cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 24, p. 14160, doi. 10.1111/jcmm.16026
- By:
- Publication type:
- Article
Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 11, p. 4585, doi. 10.1007/s12325-020-01477-w
- By:
- Publication type:
- Article
Circ_0072088 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Cancer by Absorbing miR-377.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/8967126
- By:
- Publication type:
- Article